Six-Month Standing Order � Quidel Ortho Reagents
26-003839 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Bethesda, MD, with responses due 2026-03-25. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health on behalf of the Department of Transfusion Medicine intends to award a firm-fixed-price purchase order on a sole source basis
Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| REMEL INC. | $64K | n/a | 2026-07-02 |
| CEPHEID | $306K | n/a | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $102K | 1 | 2026-07-01 |
| ROCHE DIAGNOSTICS CORPORATION | $615K | 1 | 2026-07-01 |
| ABBOTT LABORATORIES INC. | $2.8M | n/a | 2026-07-01 |
Questions
What is solicitation 26-003839?
Six-Month Standing Order � Quidel Ortho Reagents, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Bethesda, MD. Responses are due 2026-03-25.
What do similar contracts close for?
Comparable closed awards in this category ran from $64K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.